BioLife Solutions (BLFS) Misses Q3 EPS by 11c

BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.20), $0.11 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.8 million versus the consensus estimate of $31.61 million.

GUIDANCE:

BioLife Solutions sees FY2021 revenue of $115-119 million, versus the consensus of $114.4 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• PPL Corp. (PPL) Misses Q2 EPS by 4c
• SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59